These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5096072)

  • 21. The prevention of post-transfusion hepatitis: a challenge to physicians and blood banks.
    Chalmers TC; Forrest JN; Grady GF
    Trans Am Clin Climatol Assoc; 1969; 80():15-22. PubMed ID: 4185012
    [No Abstract]   [Full Text] [Related]  

  • 22. The advent of hepatitis C testing.
    Soloway HB
    MLO Med Lab Obs; 1990 Nov; 22(11):33-4, 36. PubMed ID: 10113528
    [No Abstract]   [Full Text] [Related]  

  • 23. Liability for transfusion of hepatitis-contaminated blood.
    Med Leg Bull; 1975 Aug; 24(8):1-8. PubMed ID: 1160826
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of bad blood. Transfusion risks are low, but here's how to make them even lower.
    Findlay S
    US News World Rep; 1991 Jun; 110(21):71-2. PubMed ID: 10111465
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccinate to prevent hepatitis B.
    Huff B
    GMHC Treat Issues; 2003 Oct; 17(10):6-7. PubMed ID: 14689928
    [No Abstract]   [Full Text] [Related]  

  • 26. Transfusion hepatitis arising from addict blood donors.
    Cohen SN; Dougherty WJ
    JAMA; 1968 Feb; 203(6):427-9. PubMed ID: 5694129
    [No Abstract]   [Full Text] [Related]  

  • 27. [Confrontation between the biologist and Australia antigen].
    Ropartz C; Rivat L
    Arch Fr Mal App Dig; 1971 Dec; 60(12):635-7. PubMed ID: 5158152
    [No Abstract]   [Full Text] [Related]  

  • 28. [New viewpoints in the prevention of transfusion-induced serum hepatitis (Au-SH-Antigen)].
    Pesendorfer F; Krassnitzky O
    Wien Klin Wochenschr; 1971 Aug; 83(31):576-8. PubMed ID: 5566294
    [No Abstract]   [Full Text] [Related]  

  • 29. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Australia antigen in various fractions of frozen blood.
    Werch J; Gray RE; Hersh T; Melnick JL
    JAMA; 1971 Oct; 218(1):93-4. PubMed ID: 4999423
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of donors and blood products reactive for hepatitis B virus DNA.
    Reesink HW; Allain JP
    Vox Sang; 2006 Nov; 91(4):281. PubMed ID: 17105601
    [No Abstract]   [Full Text] [Related]  

  • 33. [Australia antigen and detection of hepatic diseases in a population of blood donors. Clinical and biological study. Biological supervision of transfused patients].
    Migeotte P; Otto-Servais M; Brocteur J; Plomteux G; Ruyters L; Heusghem C; André A
    Arch Fr Mal App Dig; 1971 Dec; 60(12):637-48. PubMed ID: 5158153
    [No Abstract]   [Full Text] [Related]  

  • 34. Is your hepatitis B vaccine really protecting you?
    Clough PR
    MLO Med Lab Obs; 1994 Sep; 26(9):34, 36, 38. PubMed ID: 10138092
    [No Abstract]   [Full Text] [Related]  

  • 35. Posttransfusion hepatitis in Florida.
    Schmidt PJ
    J Fla Med Assoc; 1980 Nov; 67(11):999-1001. PubMed ID: 7452202
    [No Abstract]   [Full Text] [Related]  

  • 36. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grafting and the risk of hepatitis transmission: is there reason to be cautious? Are we cautious enough?
    Sugar J; Mannis M
    Cornea; 1997 Mar; 16(2):123-4. PubMed ID: 9071522
    [No Abstract]   [Full Text] [Related]  

  • 38. Occult hepatitis B virus (HBV) infection in healthy blood donors.
    Duseja A; Sharma S; Subramanian PG; Agnihotri SK; Chakraborti A; Chawla Y
    Indian J Pathol Microbiol; 2003 Oct; 46(4):690-2. PubMed ID: 15025384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AABB-CAP survey data on hepatitis--incidence, surveillance, and prevention.
    Polesky HF; Hanson M
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):565-8. PubMed ID: 7435449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of HBV genome by gene amplification method in HBsAg negative blood donors.
    Bodhiphala P; Chaturachumroenchai S; Chiewsilp P; Pruksananonda P
    J Med Assoc Thai; 1999 May; 82(5):491-5. PubMed ID: 10443099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.